VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
PRME
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
PRMEPrime Medicine, Inc.
$3.13$565M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksPRMEQuarterly Balance Sheet

Prime Medicine, Inc. (PRME) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Prime Medicine, Inc. (PRME) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

PRME Balance Sheet

Quarterly statement

PRME Balance Sheet

Prime Medicine, Inc. (PRME) balance sheet — 7-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Total Current Assets96.8M137.89M181.29M231.41M121.29M163.76M211.89M246.07M170.8M217.65M142.98M184.53M218.49M253.5M296.62M148.84M181.6M211.96M270.58M300.41M
Cash & Short-Term Investments95.07M135.5M177.68M208.43M101.75M144.26M190.44M175.53M162.87M210.72M121.67M165.32M207.62M249.52M293.92M146.66M180.6M211.27M269.62M299.92M
Cash Only47.45M64.11M63.03M71.4M53.8M91.88M182.48M117.98M55.6M94.16M41.57M43.96M120.58M133.46M187.62M47.95M92.24M164.25M185.42M200.66M
Short-Term Investments47.62M71.39M114.65M137.03M47.95M52.38M7.97M57.55M107.27M116.56M80.09M121.36M87.04M116.06M106.3M98.72M88.36M47.02M84.2M99.26M
Accounts Receivable0000120K17K055M000000000000
Days Sales Outstanding----5.591.05-24.21K------------
Inventory00000000000000000000
Days Inventory Outstanding--------------------
Other Current Assets1.73M2.39M3.61M22.98M19.42M16.54M14.67M9.54M3.74M2.73M2.25M19.21M10.87M3.98M246K00000
Total Non-Current Assets152.24M156.84M161.44M153.61M157.72M164.4M85.62M86.71M88.9M93.73M50.88M54.61M62.38M63.45M63.7M66.42M65.99M32.59M31.28M14.78M
Property, Plant & Equipment137.54M142.15M146.75M139.91M144.03M150.34M71.56M72.65M75.41M79.45M36.6M39.3M47.06M48.3M48.55M47.31M47.63M15.67M15.68M13.99M
Fixed Asset Turnover0.01x0.01x0.01x0.01x0.01x0.01x0.03x0.00x-0.01x----------
Goodwill00000000000000000000
Intangible Assets00000000000000000000
Long-Term Investments000013.69M000000000000000
Other Non-Current Assets14.69M14.69M14.69M13.69M014.06M14.06M14.06M13.5M14.28M14.28M15.31M15.31M15.14M15.14M19.11M18.37M16.93M15.6M794K
Total Assets249.04M294.73M342.73M385.01M279.01M328.16M297.51M332.78M259.7M311.38M193.85M239.15M280.87M316.95M360.31M215.26M247.6M244.55M301.86M315.19M
Asset Turnover0.00x0.00x0.00x0.00x0.00x0.00x0.01x0.00x-0.00x----------
Asset Growth %-10.74%-10.19%15.2%15.69%7.43%5.39%53.47%39.16%-7.53%-1.76%-46.2%11.09%13.44%29.6%19.37%-31.7%----
Total Current Liabilities31.69M36.29M37.45M35.02M34.11M34.29M37.96M37.88M20.75M24.44M56.42M39.37M28.72M23.87M26.71M22.22M23.83M12.89M57.98M9.54M
Accounts Payable5.81M12.32M8.89M9.35M6.38M10.03M11.35M5.43M4.64M10.08M19.54M14.12M5.49M4.56M4.33M4.11M5.88M3.2M1.44M1.36M
Days Payables Outstanding-514.3-16.45400.4----1.02K----------
Short-Term Debt00000000000000000000
Deferred Revenue (Current)7.93M7.32M7.82M6.95M8.31M8.21M7.09M9.28M000000000000
Other Current Liabilities8.98M4.34M9.04M8.82M6.93M6.9M10.25M8.62M5.96M4.03M9.88M6.48M5.27M2.33M6.98M4.29M2.76M1.08M14.66M12K
Current Ratio3.05x3.80x4.84x6.61x3.56x4.78x5.58x6.50x8.23x8.91x2.53x4.69x7.61x10.62x11.10x6.70x7.62x16.44x4.67x31.48x
Quick Ratio3.05x3.80x4.84x6.61x3.56x4.78x5.58x6.50x8.23x8.91x2.53x4.69x7.61x10.62x11.10x6.70x7.62x16.44x4.67x31.48x
Cash Conversion Cycle--------------------
Total Non-Current Liabilities177.54M181.74M184.42M188.17M184.04M186.95M106.4M105.4M42.37M43.18M4.36M5.82M12.04M14.27M17.33M20.34M23.03M2.8M4.31M4.27M
Long-Term Debt0105.97M108.29M00000000000000000
Capital Lease Obligations103.51M00110.42M112.48M114.29M37.18M36.76M36.37M37.04M4.36M5.82M11.93M14.2M17.05M19.86M22.76M2.09M3.07M4.27M
Deferred Tax Liabilities000000000134K00108K77K279K481K269K01.24M0
Other Non-Current Liabilities18M75.78M76.13M18M71.56M06M0000000000711K00
Total Liabilities209.23M218.03M221.87M223.19M218.15M221.24M144.36M143.28M63.12M67.62M60.78M45.19M40.76M38.15M44.04M42.56M46.86M15.69M62.3M13.81M
Total Debt112.48M114.51M116.43M118.14M119.74M121.15M40.79M41.25M41.58M43.79M13.63M17.04M25.44M25.96M28.75M31.44M34.72M8.1M10.41M9.74M
Net Debt65.03M50.41M53.4M46.74M65.93M29.27M-141.68M-76.73M-14.02M-50.37M-27.94M-26.92M-95.14M-107.5M-158.88M-16.51M-57.52M-156.15M-175.01M-190.92M
Debt / Equity2.83x1.49x0.96x0.73x1.97x1.13x0.27x0.22x0.21x0.18x0.10x0.09x0.11x0.09x0.09x0.18x0.17x0.04x0.04x0.03x
Debt / EBITDA--------------------
Net Debt / EBITDA--------------------
Interest Coverage--------------------
Total Equity39.81M76.7M120.87M161.82M60.86M106.92M153.15M189.5M196.59M243.77M133.07M193.96M240.1M278.8M316.27M172.7M200.74M228.86M239.56M301.38M
Equity Growth %-34.59%-28.27%-21.08%-14.61%-69.04%-56.14%15.09%-2.3%-18.12%-12.57%-57.92%12.31%19.61%21.82%32.02%-42.7%----
Book Value per Share0.220.430.811.010.470.821.291.581.652.331.372.112.653.133.251.782.102.392.503.15
Total Shareholders' Equity39.81M76.7M120.87M161.82M60.86M106.92M153.15M189.5M196.59M243.77M133.07M193.96M240.1M278.8M316.27M172.7M200.74M228.86M239.56M301.38M
Common Stock2K2K2K2K2K2K2K2K2K2K2K2K2K2K2K001K01K
Retained Earnings-979.59M-937.48M-888.35M-842.27M-791.69M-739.1M-687.21M-644.94M-592.42M-537.09M-491.33M-425.69M-374.98M-332.59M-293.2M-253.91M-224.56M-195.22M-171.38M-108.47M
Treasury Stock00000000000000000000
Accumulated OCI-9K-1K82K33K-10K-15K1K21K-71K-95K-15K-149K-268K-205K-384K-454K-150K-32K-27K-9K
Minority Interest00000000000000000000